FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2020/04/024539 [Registered on: 09/04/2020] Trial Registered Prospectively
Last Modified On: 31/03/2020
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Unani 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Management of urinary incontinence in Unani system of medicine. 
Scientific Title of Study   A Randomized controlled trial to study the effectiveness of Riyazat-e-Juziya for the treatment of Urinary Incontinence among women in a selected Hospital of South Delhi. 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  ARAF FATMA 
Designation  MD Scholar 
Affiliation  Jamia Hamdard 
Address  Department of Tahaffuzi wa Samaji Tibb.
School of Unani Medical Education and Research, Jamia Hamdard.
South
DELHI
110062
India 
Phone  7065185628  
Fax    
Email  afatima.fatima@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  AISHA PERVEEN 
Designation  Assistant Professor 
Affiliation  Jamia Hamdard 
Address  Department of Tahaffuzi wa Samaji Tibb.
School of Unani Medical Education and Research, Jamia Hamdard.
South
DELHI
110062
India 
Phone  9818332134  
Fax    
Email  aperveen@jamiahamdard.ac.in  
 
Details of Contact Person
Public Query
 
Name  AISHA PERVEEN 
Designation  Assistant Professor 
Affiliation  Jamia Hamdard 
Address  Department of Tahaffuzi wa Samaji Tibb.
School of Unani Medical Education and Research, Jamia Hamdard.
South
DELHI
110062
India 
Phone  9818332134  
Fax    
Email  aperveen@jamiahamdard.ac.in  
 
Source of Monetary or Material Support  
Jamia Hamdard 
 
Primary Sponsor  
Name  Jamia Hamdard 
Address  Jamia Hamdard, Hamdard Nagar, New Delhi, 110062 
Type of Sponsor  Other [University] 
 
Details of Secondary Sponsor  
Name  Address 
Department of Tahaffuzi Wa Samaji Tibb  School of Unani Medical Education and Research, Jmaia Hmadard, Hamdard Nagar, New Delhi, 110062 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Araf Fatma  OPD of Tahaffuzi wa Samaji Tibb (Room number 10) and IPD (female ward) of Majeedia Unani Hospital   Jamia Hamdard, Hamdard Nagar, New Delhi, 110062
South
DELHI 
7065185628

afatima.fatima@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
JAMIA HAMDARD INSTITUTIONAL ETHICS COMMITTEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: N394||Other specified urinary incontinence,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Majun Kundur  Majun Kundur will be given 5 grams twice a day for twelve weeks. 
Intervention  Riyazat-e-juziya and Majun Kundur  This type of exercise is performed to strengthen any organ, group of muscles or any specific part of the body. Majun Kundur will be given 5 grams twice a day for twelve weeks.  
 
Inclusion Criteria  
Age From  40.00 Year(s)
Age To  60.00 Year(s)
Gender  Female 
Details  1. Females of Age group between 40-60 years.
2. Patients with a complaint of urinary leakage.
3. Patients willing to participate in this study and are available at the time of data collection.
4. Patients who can follow commands in Hindi or English.
5. Clinically stable patients.
 
 
ExclusionCriteria 
Details  1. Patients having a chronic cough, UTI, Diagnosed patients of Diabetes Mellitus.
2. Patients on diuretics.
3. Patients with deranged kidney, hepatic and cardiac profiles.
4. Diagnosed patients of grade three Stress Urinary Incontinence.
5. Patients suffering from 2nd, 3rd or 4th-degree uterine prolapse, Urogenital Malignancy or any previously done pelvic floor surgery.
6. Participation in another study.
7. Diagnosed patients with chronic degenerative or psychiatric disorders.
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
1-hour pad testing, ICIQ-FLUTS LF (International Consultation on Incontinence Questionnaire on Female Lower Urinary Tract Symptoms long form)   0 day and 84th day 
 
Secondary Outcome  
Outcome  TimePoints 
1. CBC with ESR
2. LFT
3. KFT
4. Urine Routine & Microscopy
 
0 day and 84th day 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   15/04/2020 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   As per the guidelines laid by Jamia Hamdard 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary  

After getting ethical clearance from the ethical committee of Jamia Hamdard, Diagnosed female patients of Urinary Incontinence, fulfilling the inclusion criteria will be included in the study from OPD/IPD of Majeedia Unani Hospital, Jamia Hamdard New Delhi.

Initially, the patient will be explained about the nature of the study and informed verbal and written consent in Hindi or English will be taken from the patient by the researcher. A detailed medical history, obstetric history, family history as well as sociodemographic data along with Physical examination will be recorded in the case record form, then the patient will be allocated to the experimental or control group by randomization method. Calibration of the pocket scale machine will be obtained which will be used for the measurement of pad weight. The researcher will receive the training to perform Riyazat-e-Juziya from experts in the concerned field.

In the experimental group, Patients will be given Majun Kundur 5 grams orally twice a day, daily for twelve weeks. Along with medicine, the researcher will provide the demonstration to perform Riyazat-e-Juziya to the patients in the IBT functional room and a countercheck of Riyazat-e-Juziya understanding of the patient will be done simultaneously. Supervised Riyazat-e-Juziya will be done every week on follow up and for the rest of the days patient will perform it daily at home for twelve weeks and adherence with daily Riyazat-e-Juziya will be assessed by daily performance sheet.

In the control group, Patients will be given Majun Kundur 5 grams orally twice a day, daily for twelve weeks. They will not perform Riyazat-e-Juziya.

Change in symptoms of urinary incontinence will be assessed before and after the intervention with the help of assessment tools in both experimental as well as in the control group.

 
Close